| Views | |
|---|---|
| Favorable therapeutic response after anti-Mesothelin antibody–drug conjugate treatment requires high expression of Mesothelin in tumor cells | 179 |
| June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | |
|---|---|---|---|---|---|---|---|
| Favorable therapeutic response after anti-Mesothelin antibody–drug conjugate treatment requires high expression of Mesothelin in tumor cells | 0 | 5 | 0 | 6 | 34 | 8 | 0 |
| Views | |
|---|---|
| 2020_Lazzerini_etal.pdf | 71 |
